Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT01688492 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01688492
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.